Virtue 340B partners with HANYS Marketplace to support hospital leaders with independent 340B compliance insight and oversight clarity Virtue 340B® has partnered with HANYS Marketplace®, a
At GCA340B, staying ahead of the compliance curve isn’t just a priority—it’s the promise we make to every Covered Entity we serve. Compliance and auditing are
The 340B Drug Pricing Program is vital for safety-net healthcare providers, allowing them to enhance access to medications, reduce medication costs for vulnerable populations, and
January 1, 2026, marks a significant shift, as the Inflation Reduction Act (IRA)-driven Maximum Fair Price (MFP) pricing and the 340B Rebate Model Pilot Program
We’re excited to share that Katy’s 340B Compass — our educational video series designed to help covered entities and 340B stakeholders navigate compliance with clarity
Virtue 340B is an independent 340B compliance and audit firm dedicated to helping healthcare organizations administer their 340B programs with transparency, integrity, and confidence. We
Virtue 340B is an independent 340B compliance and audit firm dedicated to helping healthcare organizations administer their 340B programs with transparency, integrity, and confidence. We
Virtue 340B is an independent 340B compliance and audit firm dedicated to helping healthcare organizations administer their 340B programs with transparency, integrity, and confidence. We
Three years ago, Virtue 340B was built with a clear mission: to support covered entities with transparent, independent, and compliance-driven 340B audit and consulting services
The Inflation Reduction Act’s (IRA) Maximum Fair Price (MFP) requirements and HRSA’s 340B Rebate Model Pilot Program, effective in 2026, introduce major changes to drug
